Smokeless Tobacco - Pouches (not snus): Difference between revisions

(5 intermediate revisions by the same user not shown)

Line 2:

<br>

'''<big>This page is for referencing the possible benefits of Smokeless tobacco - Pouches (not Snus) AND tobacco free nicotine pouches.</big>'''

'''<big>This page is for referencing the possible benefits of Smokeless tobacco - Pouches (not Snus) AND tobacco free nicotine pouches. This [https://gsthr.org/resources/briefing-papers/what-are-nicotine-pouches/what-are-nicotine-pouches/ briefing paper] is a helpful resource to learn more about nicotine pouches.</big>'''

<br>

=Tobacco Free Nicotine Pouches - Studies, Surveys, Papers=

Line 10:

Line 13:

**Citation: Nargiz Travis, Kenneth E Warner, Maciej L Goniewicz, Hayoung Oh, Radhika Ranganathan, Rafael Meza, Jamie Hartmann-Boyce, David T Levy, The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review, Nicotine & Tobacco Research, 2024;, ntae131, https://doi.org/10.1093/ntr/ntae131

***Acknowledgment: This work was supported by the National Cancer Institute (NCI) and Food and Drug Administration (FDA) grant U54CA229974. All authors declare no conflict of interest. MLG received a research grant from Pfizer and served as a member of the scientific advisory board of Johnson & Johnson.

===2024: [https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntae047/7623369 Using pod based e-cigarettes and nicotine pouches to reduce harm for adults with low socioeconomic status who smoke: A pilot randomized controlled trial]===

*This study provides novel evidence that e-cigarettes and nicotine pouches can be a harm reduction tool for individuals with lower SES who smoke and are not willing to quit smoking, contributing to reducing tobacco-related disparities in this population.

**Citation: Avila JC, Maglalang DD, Nollen N, Lee SC, Suh R, Malone M, Binjrajka U, Ahluwalia JS. Using pod based e-cigarettes and nicotine pouches to reduce harm for adults with low socioeconomic status who smoke: A pilot randomized controlled trial. Nicotine Tob Res. 2024 Mar 6:ntae047. doi: 10.1093/ntr/ntae047. Epub ahead of print. PMID: 38447095.

***Acknowledgment: Funding and COI paywalled

===2024 [https://pubmed.ncbi.nlm.nih.gov/38713545/ Evaluating the Role of Nicotine Stereoisomer on Nicotine Pouch Abuse Liability: A Randomized Crossover Trial]===

Line 25:

Line 33:

**Citation: M. Jackson, J., Weke, A. & Holliday, R. Nicotine pouches: a review for the dental team. Br Dent J 235, 643–646 (2023). https://doi.org/10.1038/s41415-023-6383-7

***Acknowledgment: The authors declare no conflicts of interest. (Source of funding?)

===2022: [https://f1000research.com/articles/9-1225#f1 Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations<nowiki>]</nowiki> Previously titled: Nicotine products relative risk assessment: a systematic review and meta-analysis]===

*In this update, 70 new studies were added to the synthesis, making a total of 123 studies included. All combustible tobacco products score between 40 and 100, with bidis and smokeless (rest of world) also in this range. All other products have a combined risk score of 10 or less, including U.S. chewing tobacco, U.S. dipping tobacco, snus, heat-not-burn tobacco, electronic cigarettes, non-tobacco pouches and nicotine replacement therapy.

**Citation: Murkett R, Rugh M and Ding B. Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2022, 9:1225 (https://doi.org/10.12688/f1000research.26762.2)

***Acknowledgement: The research presented was produced with the help of a grant from the Foundation for a Smoke-Free World, Inc. (FSFW), an independent, US non-profit 501(c)(3) grantmaking organization with the purpose of improving global health by ending smoking in this generation. The contents, selection, and presentation of facts, as well as any opinions expressed herein, are the sole responsibility of the authors and under no circumstances should they be regarded as reflecting the positions of FSFW. FSFW accepts charitable gifts from PMI Global Services Inc. (PMI); under FSFW’s Bylaws and Pledge Agreement with PMI, FSFW is independent from PMI and the tobacco industry.

===2021: [https://link.springer.com/article/10.1007%2Fs13318-021-00742-9 A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette]===

Line 68:

Line 81:

*Please see [[SLT]] (Smokeless Tobacco) page for more details

=Suggested studies to add to this page=

=Suggested studies/articles to add to this page=

===[https://tobaccocontrol.bmj.com/content/early/2025/06/23/tc-2024-059094 Effects of oral nicotine pouches on cigarette smoking behaviour and tobacco harm exposure: a randomised pilot trial in adults]===

===[https://onlinelibrary.wiley.com/doi/10.1111/eos.12885 The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus)]===

===[https://theconversation.com/oral-nicotine-pouches-deliver-lower-levels-of-toxic-substances-than-smoking-but-that-doesnt-mean-theyre-safe-232456 Oral nicotine pouches and related ‘snus’ tobacco pouches are marketed as cigarette alternatives. Andrii Atanov/iStock via Getty Images Oral nicotine pouches deliver lower levels of toxic substances than smoking – but that doesn’t mean they’re safe]===

[[Category:Studies, Surveys, and Papers]]

@@ Line 2: / Line 2: @@
 <br>
-'''<big>This page is for referencing the possible benefits of Smokeless tobacco - Pouches (not Snus) AND tobacco free nicotine pouches.</big>'''
+'''<big>This page is for referencing the possible benefits of Smokeless tobacco - Pouches (not Snus) AND tobacco free nicotine pouches. This [https://gsthr.org/resources/briefing-papers/what-are-nicotine-pouches/what-are-nicotine-pouches/ briefing paper] is a helpful resource to learn more about nicotine pouches.</big>'''
+<br>
 =Tobacco Free Nicotine Pouches - Studies, Surveys, Papers=
@@ Line 10: / Line 13: @@
 **Citation: Nargiz Travis, Kenneth E Warner, Maciej L Goniewicz, Hayoung Oh, Radhika Ranganathan, Rafael Meza, Jamie Hartmann-Boyce, David T Levy, The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review, Nicotine & Tobacco Research, 2024;, ntae131, https://doi.org/10.1093/ntr/ntae131
 ***Acknowledgment: This work was supported by the National Cancer Institute (NCI) and Food and Drug Administration (FDA) grant U54CA229974. All authors declare no conflict of interest. MLG received a research grant from Pfizer and served as a member of the scientific advisory board of Johnson & Johnson.
+===2024: [https://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntae047/7623369 Using pod based e-cigarettes and nicotine pouches to reduce harm for adults with low socioeconomic status who smoke: A pilot randomized controlled trial]===
+*This study provides novel evidence that e-cigarettes and nicotine pouches can be a harm reduction tool for individuals with lower SES who smoke and are not willing to quit smoking, contributing to reducing tobacco-related disparities in this population.
+**Citation: Avila JC, Maglalang DD, Nollen N, Lee SC, Suh R, Malone M, Binjrajka U, Ahluwalia JS. Using pod based e-cigarettes and nicotine pouches to reduce harm for adults with low socioeconomic status who smoke: A pilot randomized controlled trial. Nicotine Tob Res. 2024 Mar 6:ntae047. doi: 10.1093/ntr/ntae047. Epub ahead of print. PMID: 38447095.
+***Acknowledgment: Funding and COI paywalled
 ===2024 [https://pubmed.ncbi.nlm.nih.gov/38713545/ Evaluating the Role of Nicotine Stereoisomer on Nicotine Pouch Abuse Liability: A Randomized Crossover Trial]===
@@ Line 25: / Line 33: @@
 **Citation: M. Jackson, J., Weke, A. & Holliday, R. Nicotine pouches: a review for the dental team. Br Dent J 235, 643–646 (2023). https://doi.org/10.1038/s41415-023-6383-7
 ***Acknowledgment: The authors declare no conflicts of interest. (Source of funding?)
+===2022: [https://f1000research.com/articles/9-1225#f1 Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations<nowiki>]</nowiki> Previously titled: Nicotine products relative risk assessment: a systematic review and meta-analysis]===
+*In this update, 70 new studies were added to the synthesis, making a total of 123 studies included. All combustible tobacco products score between 40 and 100, with bidis and smokeless (rest of world) also in this range. All other products have a combined risk score of 10 or less, including U.S. chewing tobacco, U.S. dipping tobacco, snus, heat-not-burn tobacco, electronic cigarettes, non-tobacco pouches and nicotine replacement therapy.
+**Citation: Murkett R, Rugh M and Ding B. Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2022, 9:1225 (https://doi.org/10.12688/f1000research.26762.2)
+***Acknowledgement: The research presented was produced with the help of a grant from the Foundation for a Smoke-Free World, Inc. (FSFW), an independent, US non-profit 501(c)(3) grantmaking organization with the purpose of improving global health by ending smoking in this generation. The contents, selection, and presentation of facts, as well as any opinions expressed herein, are the sole responsibility of the authors and under no circumstances should they be regarded as reflecting the positions of FSFW. FSFW accepts charitable gifts from PMI Global Services Inc. (PMI); under FSFW’s Bylaws and Pledge Agreement with PMI, FSFW is independent from PMI and the tobacco industry.
 ===2021: [https://link.springer.com/article/10.1007%2Fs13318-021-00742-9 A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette]===
@@ Line 68: / Line 81: @@
 *Please see [[SLT]] (Smokeless Tobacco) page for more details
-=Suggested studies to add to this page=
+=Suggested studies/articles to add to this page=
+===[https://tobaccocontrol.bmj.com/content/early/2025/06/23/tc-2024-059094 Effects of oral nicotine pouches on cigarette smoking behaviour and tobacco harm exposure: a randomised pilot trial in adults]===
+===[https://onlinelibrary.wiley.com/doi/10.1111/eos.12885 The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus)]===
+===[https://theconversation.com/oral-nicotine-pouches-deliver-lower-levels-of-toxic-substances-than-smoking-but-that-doesnt-mean-theyre-safe-232456  Oral nicotine pouches and related ‘snus’ tobacco pouches are marketed as cigarette alternatives. Andrii Atanov/iStock via Getty Images Oral nicotine pouches deliver lower levels of toxic substances than smoking – but that doesn’t mean they’re safe]===
 [[Category:Studies, Surveys, and Papers]]